SCHEMBL5812808

SCHEMBL5812808

CC(C)(C)OC(=O)Nc1cc(-c2[c]ccc(F)c2)ccn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK3 Q9Y572 1/20 0.41
IRAK4 Q9NWZ3 1/20 0.41
PIK3C3 Q8NEB9 4/20 0.40
TGFBR1 P36897 1/20 0.40
AAK1 Q2M2I8 9/20 0.39
GSK3B P49841 2/20 0.39
DYRK1A Q13627 1/20 0.39
ATR Q13535 1/20 0.37
CDK9 P50750 2/20 0.37
CDK1 P06493 1/20 0.37
CDK2 P24941 1/20 0.37
GSK3A P49840 1/20 0.37
CDK3 Q00526 1/20 0.37
CDK5 Q00535 1/20 0.37
GAK O14976 1/20 0.37
ROCK2 O75116 1/20 0.37
CHRNA1 P02708 1/20 0.37
SLC6A2 P23975 1/20 0.37
CHRNA7 P36544 1/20 0.37
NR2C2 P49116 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7027236 0.88 PIK3C3 (0.42) IRAK4PIK3C3TGFBR1AAK1GSK3B
SCHEMBL7026492 0.85 TGFBR1 (0.41) IRAK4PIK3C3TGFBR1AAK1GSK3B
SCHEMBL7020508 0.82 TGFBR1 (0.40) RIPK3IRAK4PIK3C3TGFBR1AAK1
SCHEMBL29402022 0.81 ATR (0.46) RIPK3IRAK4PIK3C3TGFBR1GSK3B
SCHEMBL2029613 0.81 ATR (0.46) RIPK3IRAK4PIK3C3TGFBR1GSK3B
SCHEMBL6992479 0.79 IRAK4 (0.42) RIPK3IRAK4PIK3C3TGFBR1AAK1
SCHEMBL1104982 0.78 RIPK3 (0.44) RIPK3IRAK4PIK3C3TGFBR1AAK1
SCHEMBL14694696 0.76 USP30 (0.39) PIK3C3AAK1
SCHEMBL5251219 0.75 EGFR (0.57) IRAK4PIK3C3TGFBR1AAK1GSK3B
SCHEMBL5225197 0.75 TGFBR1 (0.43) IRAK4PIK3C3TGFBR1AAK1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO disclosed
EP-1364949-A1 JNK INHIBITOR Takeda Chemical Industries, Ltd. (JP) 2003-11-26 EP disclosed